|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22,100.00 KRW | +1.14% |
|
+3.03% | +0.23% |
| Capitalization | 904B 617M 525M 488M 457M 852M 56.52B 903M 5.57B 2.21B 26.7B 2.31B 2.27B 97.7B | P/E ratio 2025 * |
-
| P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 1.42B 969K 824K 766K 718K 1.34M 88.73M 1.42M 8.74M 3.46M 41.91M 3.63M 3.56M 153M | EV / Sales 2025 * |
0.65x | EV / Sales 2026 * | 0.59x |
| Free-Float |
31.94% | Yield 2025 * |
0.9% | Yield 2026 * | 0.9% |
More valuation ratios
* Estimated data
More news
More news
| 1 day | +1.14% | ||
| 1 week | +3.03% | ||
| Current month | +0.23% | ||
| 1 month | -7.34% | ||
| 3 months | +0.45% | ||
| 6 months | -12.48% | ||
| Current year | +0.23% |
| 1 week | 21,350 |  | 22,850 |
| 1 month | 20,900 | | 24,200 |
| Current year | 20,900 | | 22,850 |
| 1 year | 17,420 | | 28,850 |
| 3 years | 11,460 | | 28,850 |
| 5 years | 11,460 | | 57,700 |
| 10 years | 6,470 | | 86,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jae-Chun Yoon
CEO | Chief Executive Officer | 66 | 2015-03-19 |
Woo-Bang Jeon
AUD | Comptroller/Controller/Auditor | 64 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jae-Chun Yoon
BRD | Director/Board Member | 66 | 2013-12-30 |
Seong-Soo Park
BRD | Director/Board Member | 50 | 2021-03-25 |
In-Hyuk Choi
BRD | Director/Board Member | 54 | 2023-03-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.14% | +3.03% | +7.80% | +10.78% | 610M | |
| +1.32% | -3.91% | -7.29% | +58.61% | 42.25B | |
| +1.89% | -0.34% | +13.86% | +119.50% | 29.92B | |
| +0.06% | -4.47% | -4.03% | +30.09% | 12.08B | |
| +1.03% | +0.18% | -10.20% | +102.03% | 9.63B | |
| -4.17% | -5.66% | +59.71% | +33.20% | 8.24B | |
| +2.27% | +1.81% | +41.51% | +132.44% | 7.84B | |
| -.--% | +0.14% | - | - | 6.79B | |
| +0.91% | -0.90% | +40.23% | -21.78% | 6.67B | |
| +2.87% | -0.70% | +33.19% | +377.91% | 5.98B | |
| Average | +0.73% | -1.97% | +19.42% | +93.64% | 13B | |
| Weighted average by Cap. | +1.00% | -3.17% | +10.14% | +87.90% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2,166B 1.48B 1.26B 1.17B 1.1B 2.04B 135B 2.16B 13.35B 5.29B 63.99B 5.55B 5.43B 234B | 2,421B 1.65B 1.41B 1.31B 1.23B 2.28B 151B 2.42B 14.92B 5.91B 71.53B 6.2B 6.07B 262B |
| Net income | - | - |
| Net Debt | 515B 352M 299M 278M 261M 485M 32.21B 515M 3.17B 1.26B 15.21B 1.32B 1.29B 55.68B | 522B 356M 303M 282M 264M 492M 32.65B 521M 3.22B 1.27B 15.42B 1.34B 1.31B 56.43B |
More financial data
* Estimated data
Employees
379
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-21 | 22,100.00 ₩ | +1.14% | 91,608 |
| 26-01-21 | 21,850.00 ₩ | -1.80% | 111,411 |
| 26-01-20 | 22,250.00 ₩ | +2.77% | 140,329 |
| 26-01-19 | 21,650.00 ₩ | +0.23% | 81,090 |
| 26-01-16 | 21,600.00 ₩ | -1.82% | 123,229 |
End-of-day quote Korea S.E., January 21, 2026
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
22,100.00KRW
Average target price
28,000.00KRW
Spread / Average Target
+26.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A003090 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition